21585286|t|Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer's disease.
21585286|a|beta-site APP-cleaving enzyme (BACE1) cleaves the wild type (WT) beta-site very slowly (k(cat)/K(m): 46.6 m(-1) s(-1)). Therefore we searched for additional beta-secretases and identified three cathepsins that split the WT beta-site much faster. Human cathepsin S cleaves the WT beta-site (k(cat)/K(m): 54 700 m(-1) s(-1)) 1170-fold faster than BACE1 and cathepsins B and L are 440- and 74-fold faster than BACE1, respectively. These cathepsins split two bonds flanking the WT beta-site (K-MD-A), where the K-M bond (85%) is cleaved more efficiently than the D-A bond (15%). Cleavage at the major K-M bond yields Abeta (amyloid beta-peptide) extended by N-terminal Met that should be removed to generate Abeta initiated by Asp1. The activity of cytosol and microsomal aminopeptidases on relevant peptides revealed rapid removal of N-terminal Met but not N-terminal Asp. Brain aminopeptidases showed similar specificity. Thus, aminopeptidases would convert Abeta extended by Met into regular Abeta (Asp1) found in amyloid plaques. Earlier studies indicate that Abeta is likely produced in the endosome and lysosome system where cathepsins S, B and L are localized and cysteine cathepsin inhibitors reduce the level of Abeta in cells and animals. Taken together, cathepsins S, B and L deserve further evaluation as therapeutic targets to develop disease modifying drugs to treat Alzheimer's disease.
21585286	0	21	Cathepsins S, B and L	Gene	1520;1508;1514
21585286	111	130	Alzheimer's disease	Disease	MESH:D000544
21585286	132	161	beta-site APP-cleaving enzyme	Gene	23621
21585286	163	168	BACE1	Gene	23621
21585286	326	336	cathepsins	Gene	1520
21585286	378	383	Human	Species	9606
21585286	384	395	cathepsin S	Gene	1520
21585286	477	482	BACE1	Gene	23621
21585286	487	505	cathepsins B and L	Gene	1508;1514
21585286	539	544	BACE1	Gene	23621
21585286	566	576	cathepsins	Gene	1520
21585286	745	750	Abeta	Gene	351
21585286	797	800	Met	Chemical	MESH:D008715
21585286	836	841	Abeta	Gene	351
21585286	855	859	Asp1	Gene	25825
21585286	974	977	Met	Chemical	MESH:D008715
21585286	997	1000	Asp	Chemical	MESH:D001224
21585286	1088	1093	Abeta	Gene	351
21585286	1106	1109	Met	Chemical	MESH:D008715
21585286	1123	1128	Abeta	Gene	351
21585286	1130	1134	Asp1	Gene	25825
21585286	1145	1160	amyloid plaques	Disease	MESH:D058225
21585286	1192	1197	Abeta	Gene	351
21585286	1259	1280	cathepsins S, B and L	Gene	1520;1508;1514
21585286	1349	1354	Abeta	Gene	351
21585286	1393	1414	cathepsins S, B and L	Gene	1520;1508;1514
21585286	1509	1528	Alzheimer's disease	Disease	MESH:D000544
21585286	Positive_Correlation	MESH:D008715	351
21585286	Association	MESH:D000544	1508
21585286	Association	MESH:D058225	351
21585286	Association	MESH:D000544	1514
21585286	Positive_Correlation	25825	351
21585286	Association	MESH:D058225	25825
21585286	Association	MESH:D000544	1520

